Head-to-head · Cost-Efficiency Index
Rivo Health vs NuuVim
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rivo Health
Patients willing to commit to a 12-month prepay plan to reach the advertised $149-199/mo rate, who also want dietitian and coaching support bundled in.
Visit Rivo HealthNuuVim
Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Visit NuuVimThe verdict
Rivo Health takes it, leading the Cost-Efficiency Index 71 to 70. Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members claimed, Trustpilot 4.7) whose advertised $149/mo semaglutide and $199/mo tirzepatide are the 12-month annual-plan rate, not month-to-month. NuuVim still earns a C — Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rivo Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rivo Health | NuuVim |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 70/100 |
| Semaglutide / mo | $149/mo (starting dose, annual plan, compounded oral) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide / mo | $199/mo (starting dose, annual plan, compounded oral) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $948 |
| Tirzepatide / yr (modeled) | $2,388 | $1,596 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #83 | #88 |
Rivo Health
71/100Where the value is
- Bundles a membership (unlimited provider visits, dietitian, coaching) into the plan at no separately-billed cost
- Large, established program with a stated 115,000+ member base and 4.7 Trustpilot rating
- Both injectable and oral compounded options for semaglutide and tirzepatide
The tradeoffs
- The headline $149/$199 prices require a 12-month annual-plan commitment — the genuine month-to-month rate, shown crossed out on the same page, is $279/mo and $389/mo, 87-95% higher
- Compounding pharmacy partner is not named anywhere reachable
NuuVim
70/100Where the value is
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
The tradeoffs
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.